Patterns of expression of tumor necrosis factor α, tumor necrosis factor β, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy

Arthritis and Rheumatism

Volumn 39, Issue 10, 1996, Pages 1703-1710

  Grom, Alexei A ^a   Murray, Kevin J ^a   Luyrink, Lorie ^a   Emery, Helen ^b   Passo, Murray H ^a   Glass, David N ^a,e   Bowlin, Terry ^c   Edwards III, Carl ^c,d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Merrell Dow Research Institute   (United States)

^d AMGEN INC   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ARTICLE; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JUVENILE RHEUMATOID ARTHRITIS; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONDYLOARTHROPATHY; SYNOVIUM; T LYMPHOCYTE ACTIVATION; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIUM;

EID: 0029766227     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780391013     Document Type: Article

References (33)

1. Beutler B: TNF, immunity and inflammatory disease: lessons of the past decade. J Invest Med 43:227-235, 1995
2. Brennan FM, Maini RN, Feldman M: TNF-α - a pivotal role in rheumatoid arthritis? Br J Rheumatol 31:293-298, 1992
3. Chu CQ, Field M, Feldmann M, Maini RN: Localization of tumor necrosis factor α in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 34:1125-1132, 1992
4. Deleuran BW, Chu C-Q, Field M, Brennan FM, Mitchell T, Feldmann M, Maini RN: Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis: implications for local actions of tumor necrosis factor α. Arthritis Rheum 35:1170-1178, 1992
5. William DR, Feldman M, Maini RN: Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci U S A 89:9784-9788, 1992
6. Elliot MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H, Woody JN: Randomized double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor TNF-α (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105-1110, 1994
7. Rankin ECC, Choy EHS, Kassimos D, Kingsley GH, Sopwith M, Isenberg DA, Panayi G: The therapeutic effects of an engineered human anti-TNF-α antibody (CDP571) in rheumatoid arthritis. Br J Rheumatol 34:334-342, 1995
8. Elliott MJ, Woo P, Charles P, Long-Fox A, Woody JN, Maini RN: Treatment of systemic juvenile chronic arthritis with monoclonal anti-TNFα - temporary control of systemic but not articular features of disease (abstract). Arthritis Rheum 37 (suppl 9):S276, 1994
9. Cassidy JT, Levinson JE, Bass JC, Baum J, Brewer EJ Jr, Fink CW, Hanson V, Jacobs JC, Masi AT, Schaller JG, Fries JF, McShane D, Young D: A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 29: 274-281, 1986
10. Ruddle NH: Tumor necrosis factor (TNF-α) and lymphotoxin (TNF-β). Curr Opin Immunol 4:327-332, 1992
11. Murray KJ, Luyrink L, Grom AA, Passo MH, Emery H, Witte D, Glass DN: Immunohistological characteristics of T cell infiltrates indifferent forms of childhood onset chronic arthritis. J Rheumatol (in press)
12. Eberhard A, Laxer RM, Andersson U, Silverman ED: Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritis.Clin Exp Immunol 96:260-266, 1994
13. Saxne T, Palladino MA Jr, Heinegård D, Talal N, Wollheim FA: Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 31:1041-1045, 1988
14. Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H: Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci U S A 87:8667-8671, 1990
15. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
16. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, Dijkmans B, Olivieri I, Pasero G, Veys E, Zeidler H, the European Spondylarthropathy Study Group: The European Spondylarthropathy Study Group preliminary criteria for the classification of Spondylarthropathy. Arthritis Rheum 34:1218-1227, 1991
17. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Ann Biochem 162:156-159, 1987
18. Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, Eggens U, Distler A, Sieper J: Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 38:499-505, 1995
19. Bertollini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR: Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factor. Nature 319:516-518, 1986
20. Saklatvala J: Tumor necrosis factor a stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 322:547-549, 1986
21. Dayer JM, Beutler B, Cerami A: Cachetin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 162:2163-2168, 1985
22. Brennan FM, Chantry D, Jackson A, Maini RN: Inhibitory effect of TNF-α antibodies on synovial cell interleukin production. Lancet 11:244-247, 1989
23. Crowe PD, van Arsdale TL, Walter BN, Ware CF, Hession C, Ehrenfels B, Browning JL, Din WS, Goodwin RG, Smith CA: A lymphotoxin-β-specific receptor. Science 264:707-710, 1994
24. De Togni P, Goellner J, Ruddle NH, Streeter PR, Fick A, Mariathasan S, Smith SC, Careson R, Shornick LP, Strauss-Schoenberger J, Russel JH, Karr R, Chaplin DD: Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264:703-707, 1994
25. Silveiman ED, Smith RL, Schurman DD, Miller JJ: Spontaneous secretion of a proteoglycan releasing factor by mononuclear cells in juvenile arthritis. J Rheumatol 14:540-547, 1987
26. Key LL, Hoch S, Cairns K, Carnes D, Beyer E, Anast CS: Monocyte bone degradation: in vitro analysis of monocyte activity in patients with juvenile rheumatoid arthritis. J Pediatr 108:405-409, 1986
27. Cavender D, Saegusa Y, Ziff M: Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor. J Immunol 139:1855-1860, 1987
28. Butcher EC: Cellular and molecular mechanisms that direct leukocyte traffic. Am J Pathol 136:3-11, 1990
29. Oen K, Danell G, Stewart S, Wilkins J, Tazumi K, Jacobson K: Adhesion of peripheral blood lymphocytes of children with arthritis to human umbilical vein endothelial cells. Clin Exp Immunol 95:415-423, 1994
30. Webb GC, Chaplin DD: Genetic variability at the human tumor necrosis factor loci. J Immunol 145:1278-1285, 1990
31. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO: Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor a: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A 87:1233-1237, 1990
32. Jongeneel CV, Briant L, Udalova IA, Sevin A, Nedospasov SA, Cambon-Thomsen A: Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes. Proc Natl Acad Sci U S A 88:9717-9721, 1991
33. Wilson AG, de Vries N, Pociot F, di Giovine FS, van de Putte LBA, Duff GW: An allelic polymorphism within the human tumor necrosis factor a promoter region is strongly associated with HLA A1, B 8 and DR3 alleles. J Exp Med 177:577-580, 1993